A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.

Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, Cuong DD, Phuc PTH, Vinh VH, Hanh DTH, Tam VV, Thanh NT, Thuy TP, Hang NT, Long HB, Nhan HT, Wertheim HFL, Merson L, Shikuma C, Day JN, Chau NVV, Farrar J, Thwaites G, Wolbers M. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. N Engl J Med. 2017 06 15; 376(24):2329-2340.

View in: PubMed

subject areas

Administration, Oral
Adult
AIDS-Related Opportunistic Infections
Amphotericin B
Antifungal Agents
Creatinine
Deoxycholic Acid
Drug Combinations
Female
Humans
Infusions, Intravenous
Itraconazole
Male
Mycoses
Talaromyces

authors with profiles

Cecilia M. Shikuma,MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support